1995至2014年间肾移植供受体风险增高但移植物存活率改善
该研究基于澳大利亚和新西兰透析与移植登记系统1995至2014年首次肾移植受者数据,随访至2021年底,评估移植时代与5年及10年移植物失败风险的关系。结果显示尽管供受体风险特征增高,5年和10年移植物失败风险均显著下降,排斥、血管性原因、死亡及肾小球疾病导致的失败减少。
要点
- 近20年肾移植受者年龄更大、合并症更多、透析时间更长、BMI更高、HLA错配更多,供者年龄也增加。
- 与1995-99年相比,2000-04、2005-09、2010-14年5年移植物失败调整风险比分别为0.78、0.70、0.60。
- 10年移植物失败风险从2000-04年的0.83降至2010-14年的0.78(与1995-99年比较)。
核心结论
- 自1995-99年以来,中远期全因移植物失败风险稳步改善。
- 5年移植物失败因排斥和血管性原因显著减少,10年失败因排斥、血管性原因、死亡和肾小球疾病减少。
研究设计与样本
- 回顾性队列研究,数据来自澳大利亚和新西兰透析与移植登记系统。
- 主要暴露为移植时代(每5年一组),主要结局为全因5年移植物失败;采用Kaplan-Meier曲线、多因素Cox回归和Fine-Gray竞争风险模型分析。
主要发现
- 受者特征向年龄>45岁、合并症更多、透析龄更长、BMI>30 kg/m2和HLA错配更多转变;供者年龄增加,供者来源无明确变化。
- 与1995-99年相比,2000-04、2005-09、2010-14年5年移植物失败调整风险比分别为0.78(95%CI 0.67-0.91)、0.70(95%CI 0.59-0.83)、0.60(95%CI 0.50-0.73)。
- 与1995-99年相比,10年移植物失败调整风险比在2000-04年为0.83(95%CI 0.74-0.93),2010-14年为0.78(95%CI 0.68-0.89)。
临床怎么用
- 在供受体风险特征增高的背景下,肾移植中远期移植物存活仍持续改善。
- 应关注排斥、血管性原因、死亡及肾小球疾病等特定原因导致的移植物失败,以进一步优化管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND HYPOTHESIS: Advances in organ procurement, surgical techniques, immunosuppression regimens, and prophylactic antibiotic therapies have dramatically improved kidney transplant graft failure. It is unclear how these interventions have affected longer-term graft failure. It is hypothesized that graft failure has improved over the last 20 years. METHODS: Data on all first kidney transplants from 1995 to 2014 were extracted from the Australia and New Zealand Dialysis and Transplant Registry with follow-up as of 31 December 2021. Primary exposure was transplant era, classified into 5-year intervals. Primary outcome was all-cause 5-year graft failure. Secondary outcomes included all-cause 10-year graft failure and cause-specific graft failure. Kaplan-Meier curves and multivariable Cox proportional hazards regression models were used to assess trends in all-cause graft failure. Fine-Gray subdistribution hazard models verified that changes in death rates were not biasing the Cox proportional hazards regression models. Cumulative incidence functions were used to assess temporal trends in cause-specific graft failure. RESULTS: Across 10 871 kidney transplants, there was a shift towards transplanting more recipients aged >45 years old, with more comorbidities, longer dialysis vintage, body mass index >30 kg/m2, and greater human leukocyte antigen mismatches. Donor age has increased but no clear shift in donor source was observed. Compared to 1995-99 (reference), the adjusted hazard ratio for 5-year graft failure was 0.78 (95% CI 0.67-0.91), 0.70 (95% CI 0.59-0.83), and 0.60 (95% CI 0.50-0.73) for 2000-04, 2005-09, and 2010-14, respectively. Ten-year graft failure similarly reduced from 0.83 (95% CI 0.74-0.93) for 2000-04 to 0.78 (95% CI 0.68-0.89) for 2010-14, compared to 1995-99. CONCLUSION: Medium- and long-term all-cause graft failure has improved steadily since 1995-99. Significant reductions in graft failure due to rejection and vascular causes were observed at 5 years, and due to rejection, vascular causes, death, and glomerular disease at 10 years.
引用
- Ng MSY, Jones AT, Mallett AJ, et al. Better kidney allograft survival despite higher-risk donor and recipient characteristics between 1995 and 2014. Nephrol Dial Transplant. 2024. PMID: 38573827. doi:10.1093/ndt/gfae081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。